Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Carasent

27.05 SEK

-0.73 %

1,644 following

CARA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

-0.73 %
-1.28 %
-0.73 %
-5.75 %
+21.85 %
+30.66 %
+58.27 %
-1.89 %
+22.30 %

Carasent is an IT company. The company delivers a wide range of products and services in communication and IT infrastructure specifically aimed at the healthcare industry. Examples of solutions include proprietary cloud-based services, email management, mobile solutions, and security solutions. Customers are mainly found in health and care, finance, and telecom. The company was originally established in 1997 and is headquartered in Gothenburg.

Read more
Market cap
1.96B SEK
Turnover
573.46K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.2.
2026

Annual report '25

14.4.
2026

Interim report Q1'26

20.4.
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Carnegielta commissioned research pre-Q4 Inderes Carnegie Access: Carasent: We expect a solid end to the year – Q4 preview -... Carnegie has published a new commissioned research report on Carasent.To access the full report and subscribe to future updates, visit https://www.carnegie...
1/29/2025, 6:41 AM
by timontti
6
redeye.se Carasent (Q3 Review): In good shape for exciting 2026 Redeye retains its positive view of Carasent following the Q3 report. Organic ARR growth remains solid, and margins are improving substantially. The company has several ongoing growth initiatives tha Carasent’s profitability...
10/16/2025, 3:46 PM
by Diviner
2
I have thousands of euros worth of Carasent ASA. It is no longer traded, so I am stuck with the shares. I thought there would have been an automatic exchange to Carasent AB… Is anyone else in the same situation? What should I do? How can I prevent this in the future?
6/23/2025, 7:38 AM
by Loue
1
redeye.se Carasent: Back in Shape in 2024 – More to Come Redeye retains its positive view of Carasent following the Q4 report. Despite a somewhat softer Q4 report than expected and a softened outlook for H1 2025, we changed our Base Case driven by revised New Base Case SEK28 (NOK26...
2/17/2025, 6:47 AM
by timontti
1
Redeye odotuksia 13.2. osariin
2/6/2025, 3:08 PM
by timontti
1
Inderes First day of trading in Carasent AB (publ) on Nasdaq Stockholm - Inderes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND...
12/9/2024, 9:27 AM
by timontti
1
Which intermediary? Contact them, and the matter should be resolved.
6/23/2025, 1:51 PM
by Turskanpyytäjä
0
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.